Primer és szekunder májdaganatos betegek lipiodolos kemoembolizációval végzett helyi kezelésének klinikai értékelése.

C. András, Z. Szúcs Farkas, Z. Csiki, I. Gál, I. Takács, P. Sápy, P. Molnár

Research output: Article

2 Citations (Scopus)

Abstract

The authors treated with locoregional lipiodol chemoembolization 32 patients suffering from primary and secondary liver malignancies. They present the clinical results of the 22 patients who received at least 2 treatments. Distribution of patients: 17 men, 5 women, mean age 56.2 (43-80) years. Seven patients suffered from primary liver carcinoma; regarding the Child's staging of the tumors 4 patients were in Child A, 3 patients in Child B. In 15 cases the treatment indication was secondary liver cancer. The primary tumors in these secondary liver cancer cases were: one case lung cancer, 11 colon (2 cases rectum) cancer, 2 cases pancreas cancer, one case gastric carcinoma. The 22 patients received in total 97 cycles of therapy. After the selective catheterisation of the hepatic artery adriamycin, mitomycin C, 5-fluorouracil or lipiodol was administered. During the mean follow up time of 9 months (3-15 months) remission could be observed in 6/22 patients. The side effects were preventable or medically treatable. It can be concluded that in the case of well-selected cases of non-resectable liver malignancies local chemoembolization could be beneficial, as it could slow down the progression of the underlying disease with the maintainment or even improvement of the quality of life.

Original languageHungarian
Pages (from-to)1773-1777
Number of pages5
JournalOrvosi Hetilap
Volume141
Issue number32
Publication statusPublished - aug. 6 2000

Fingerprint

Ethiodized Oil
Liver
Neoplasms
Therapeutics
Liver Neoplasms
Carcinoma
Neoplasm Staging
Hepatic Artery
Mitomycin
Rectal Neoplasms
Pancreatic Neoplasms
Catheterization
Fluorouracil
Doxorubicin
Colonic Neoplasms
Disease Progression
Lung Neoplasms
Stomach
Quality of Life

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Primer és szekunder májdaganatos betegek lipiodolos kemoembolizációval végzett helyi kezelésének klinikai értékelése. / András, C.; Szúcs Farkas, Z.; Csiki, Z.; Gál, I.; Takács, I.; Sápy, P.; Molnár, P.

In: Orvosi Hetilap, Vol. 141, No. 32, 06.08.2000, p. 1773-1777.

Research output: Article

@article{6cbf4c461c6c481c98f268027a94d73a,
title = "Primer {\'e}s szekunder m{\'a}jdaganatos betegek lipiodolos kemoemboliz{\'a}ci{\'o}val v{\'e}gzett helyi kezel{\'e}s{\'e}nek klinikai {\'e}rt{\'e}kel{\'e}se.",
abstract = "The authors treated with locoregional lipiodol chemoembolization 32 patients suffering from primary and secondary liver malignancies. They present the clinical results of the 22 patients who received at least 2 treatments. Distribution of patients: 17 men, 5 women, mean age 56.2 (43-80) years. Seven patients suffered from primary liver carcinoma; regarding the Child's staging of the tumors 4 patients were in Child A, 3 patients in Child B. In 15 cases the treatment indication was secondary liver cancer. The primary tumors in these secondary liver cancer cases were: one case lung cancer, 11 colon (2 cases rectum) cancer, 2 cases pancreas cancer, one case gastric carcinoma. The 22 patients received in total 97 cycles of therapy. After the selective catheterisation of the hepatic artery adriamycin, mitomycin C, 5-fluorouracil or lipiodol was administered. During the mean follow up time of 9 months (3-15 months) remission could be observed in 6/22 patients. The side effects were preventable or medically treatable. It can be concluded that in the case of well-selected cases of non-resectable liver malignancies local chemoembolization could be beneficial, as it could slow down the progression of the underlying disease with the maintainment or even improvement of the quality of life.",
author = "C. Andr{\'a}s and {Sz{\'u}cs Farkas}, Z. and Z. Csiki and I. G{\'a}l and I. Tak{\'a}cs and P. S{\'a}py and P. Moln{\'a}r",
year = "2000",
month = "8",
day = "6",
language = "Hungarian",
volume = "141",
pages = "1773--1777",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "32",

}

TY - JOUR

T1 - Primer és szekunder májdaganatos betegek lipiodolos kemoembolizációval végzett helyi kezelésének klinikai értékelése.

AU - András, C.

AU - Szúcs Farkas, Z.

AU - Csiki, Z.

AU - Gál, I.

AU - Takács, I.

AU - Sápy, P.

AU - Molnár, P.

PY - 2000/8/6

Y1 - 2000/8/6

N2 - The authors treated with locoregional lipiodol chemoembolization 32 patients suffering from primary and secondary liver malignancies. They present the clinical results of the 22 patients who received at least 2 treatments. Distribution of patients: 17 men, 5 women, mean age 56.2 (43-80) years. Seven patients suffered from primary liver carcinoma; regarding the Child's staging of the tumors 4 patients were in Child A, 3 patients in Child B. In 15 cases the treatment indication was secondary liver cancer. The primary tumors in these secondary liver cancer cases were: one case lung cancer, 11 colon (2 cases rectum) cancer, 2 cases pancreas cancer, one case gastric carcinoma. The 22 patients received in total 97 cycles of therapy. After the selective catheterisation of the hepatic artery adriamycin, mitomycin C, 5-fluorouracil or lipiodol was administered. During the mean follow up time of 9 months (3-15 months) remission could be observed in 6/22 patients. The side effects were preventable or medically treatable. It can be concluded that in the case of well-selected cases of non-resectable liver malignancies local chemoembolization could be beneficial, as it could slow down the progression of the underlying disease with the maintainment or even improvement of the quality of life.

AB - The authors treated with locoregional lipiodol chemoembolization 32 patients suffering from primary and secondary liver malignancies. They present the clinical results of the 22 patients who received at least 2 treatments. Distribution of patients: 17 men, 5 women, mean age 56.2 (43-80) years. Seven patients suffered from primary liver carcinoma; regarding the Child's staging of the tumors 4 patients were in Child A, 3 patients in Child B. In 15 cases the treatment indication was secondary liver cancer. The primary tumors in these secondary liver cancer cases were: one case lung cancer, 11 colon (2 cases rectum) cancer, 2 cases pancreas cancer, one case gastric carcinoma. The 22 patients received in total 97 cycles of therapy. After the selective catheterisation of the hepatic artery adriamycin, mitomycin C, 5-fluorouracil or lipiodol was administered. During the mean follow up time of 9 months (3-15 months) remission could be observed in 6/22 patients. The side effects were preventable or medically treatable. It can be concluded that in the case of well-selected cases of non-resectable liver malignancies local chemoembolization could be beneficial, as it could slow down the progression of the underlying disease with the maintainment or even improvement of the quality of life.

UR - http://www.scopus.com/inward/record.url?scp=17644432048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17644432048&partnerID=8YFLogxK

M3 - Article

C2 - 10979306

AN - SCOPUS:17644432048

VL - 141

SP - 1773

EP - 1777

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 32

ER -